{{Rsnum
|rsid=1438949
|Chromosome=5
|position=153125369
|Orientation=minus
|GMAF=0.06703
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 87.6 | 11.5 | 0.9
| HCB | 89.0 | 10.3 | 0.7
| JPT | 94.6 | 5.4 | 0.0
| YRI | 79.6 | 18.4 | 2.0
| ASW | 71.9 | 24.6 | 3.5
| CHB | 89.0 | 10.3 | 0.7
| CHD | 86.1 | 13.9 | 0.0
| GIH | 89.0 | 11.0 | 0.0
| LWK | 86.4 | 13.6 | 0.0
| MEX | 98.3 | 1.7 | 0.0
| MKK | 83.7 | 15.0 | 1.3
| TSI | 85.3 | 14.7 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=6E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}